Letter from Kleinfeld Kaplan and Becker LLP to CFSAN

Click to download
Reviews
Shared by: FDADocs
Stats
views:
46
rating:
not rated
reviews:
0
posted:
5/9/2008
language:
English
pages:
0
THOMAS RICHARD KlNSEY PETER ANTHONY ANNE BONNIE DANIEL GLENN STACY JENNIFER STACEY JONATHAN OF COVNSEL L. V. S. R. 0. 5. HENTELEFF MOREY REAGAN MATHERS L. YOUNG BEAVERS DWYER DAVtS LAW OFFICES KLEINFELD,KAPLANANDBECKER, 1140 NINETEENTH STREET, N.W. LLP SAN WEST ONE STEUART TELEPHONE FACSIMILE COAST MARKET TOWER, (415) (415) OFFICE: STREET SUITE CA 536-0014 538-0016 1450 94105-1313 MAHER A. R. E. WASHINGTON, TELEPHONE FACSIMILE D. C. (202) (202) 20036-6606 223-5120 223-5619 FRANCISCO, EHRLlCH A. L. M. DA”IDSON WEINRIEB VALERIO VINCENT A. KLEINFELD www kkblawxom ALAN 1907-1993 H. KAPLAN 1930-2001 A. J. SUSSMAN HARDY HARVEY WlLLlAM December 1,2004 VIA OVERNIGHT MAIL Division of Standards and Labeling Regulations Office of Nutritional Products, Labeling, and Dietary Supplements (HFS-820) Center for Food Safety and Applied Nutrition Food and Drug Administration 5 100 Paint Branch Parkway, Building CPKl College Park, Maryland 20740-3835 RE: Amendment to New Dietary Ingredient (Nor) NotcjZcation for Safflorin T”dated November 9,2004, submitted by Loders Croklaan B. V. To Whom It May Concern: On behalf of Loders Croklaan B.V., and in response to a telephone conversation of November 30,2004, between Linda Pellicore and Carmen Booker of FDA, and the undersigned, this letter amends the above-referenced new dietary ingredient (NDI) notification for SafflorinTM as follows: 1. Section 2 of the notification (p. 3) is revised to include the statement, “Loders Croklaan is a bulk manufacturer of Safflorin TM; it does not manufacture finished dietary supplements containing SafflorinTM.” 2. In section 4 of the notification (p. 4), the 2nd sentence is deleted and replaced by the following: “Loders Croklaan recommends that dietary supplement manufacturers formulate products to provide a daily intake of 2.0 g SafflorinTM, which may be consumed at any time during the day in one or more separate consumption occasions.” 3. In section 4 of the notification (p. 4), the 3’ sentence is deleted and replaced by d the following: “The ingredient is intended for use by persons who wish to KLEINFELD,KAPLANANDBECKER, Center for Food Safety and Applied Nutrition December 1,2004 Page 2 LLP maintain or enhance their natural resistance to stress, including everyday fatigue and environmental stress.” Counsel to Loders Croklaan B.V. cc: Linda Pellicore Carmen Booker Via Facsimile: 301-436-2636

Related docs
LET Kleinfeld Kaplan Becker Vol
Views: 36  |  Downloads: 0
PDN HFC to Kleinfeld Kaplan Becker Vol
Views: 33  |  Downloads: 0
PAV HFD to Kleinfeld Kaplan Becker Vol
Views: 32  |  Downloads: 0
PAV HFD to Kleinfeld Kaplan and Backer Vol
Views: 16  |  Downloads: 0
Letter from CFSAN to Ullman Shapiro Ullman LLP
Views: 36  |  Downloads: 0
Letter from Ullman Shapiro Ullman LLP to CFSAN
Views: 33  |  Downloads: 0
Letter from CFSAN to Patton Boggs LLP RPT275
Views: 13  |  Downloads: 0
Other docs by FDADocs
Announcement of Change of Address for Billing
Views: 371  |  Downloads: 4
Closed Memo Final Draft
Views: 370  |  Downloads: 15
Essay Workshop Day 1[1]
Views: 674  |  Downloads: 79
EVIDENCE NOTES3
Views: 186  |  Downloads: 10
Acceptance of forthcoming payment schedule
Views: 254  |  Downloads: 3
Evidence Exam Answers
Views: 1924  |  Downloads: 49
Lead Paint Disclosure Forms-CA
Views: 377  |  Downloads: 14
Affiliate Masters Course
Views: 1194  |  Downloads: 108
Compliment about employee of another firm
Views: 165  |  Downloads: 1
Law School Outline - Constitutional Law
Views: 2083  |  Downloads: 332
Kriya_sMcGConlawshortreviewoutline
Views: 231  |  Downloads: 15
Evidence INTRODUCTION
Views: 234  |  Downloads: 6
Appendix C - forest service
Views: 137  |  Downloads: 0
Final Outline RP
Views: 185  |  Downloads: 3